IonQ's Quantum Leap Faces FTC Scrutiny as Revenue Skyrockets 555%

IonQ reports Q1 2026 earnings with 555% revenue growth to ~$49.7M, but losses widen 86% as FTC reviews its $1.8B SkyWater acquisition.

When IonQ reports its first-quarter 2026 earnings after the closing bell today, the numbers will tell a story of staggering growth — but also of mounting losses that threaten to overshadow the company's quantum computing ambitions.

Analysts are bracing for revenue of roughly $49.7 million, representing a 555% surge from the same period last year. The company's own guidance of $48 million to $51 million suggests management is targeting the upper end of that range. Yet even those eye-popping figures signal a deceleration from the fourth quarter of 2025, when IonQ posted 429% growth.

The full-year 2025 results already set a milestone: $130 million in revenue, a 202% increase, making IonQ the first publicly traded quantum company to surpass $100 million in GAAP annual revenue. A remaining backlog of $370 million — with over 60% of 2025 sales coming from enterprise clients — provides some visibility into future performance.

The SkyWater Deal Hangs in the Balance

But the headline numbers aren't the only thing keeping investors on edge. IonQ's planned $1.8 billion acquisition of chipmaker SkyWater Technology, announced in January, has drawn the attention of the Federal Trade Commission. The regulator issued a Second Request — a deep-dive review that extends the waiting period by at least 30 days after both companies have fully complied. IonQ and SkyWater still expect to close the deal in the second or third quarter, assuming all conditions are met.

CEO Niccolò de Masi will almost certainly face questions about the FTC's scrutiny during today's earnings call. The acquisition is central to IonQ's strategy of building its own quantum chips and securing its supply chain — a bet that becomes riskier the longer regulators deliberate.

The Cost of Growth

The flip side of IonQ's explosive revenue is a rapidly widening loss profile. Analysts expect a loss of $0.26 per share for Q1, an 86% deterioration from the year-ago quarter. For the full year 2026, management projects an adjusted EBITDA loss of $310 million to $330 million.

Liquidity isn't an immediate concern — pro-forma cash stands at roughly $3.5 billion. But the company burned $283 million in operating cash during 2025, a pace that raises questions about how long that runway will last.

The valuation math is equally unforgiving. IonQ trades at 59.3 times forward sales, compared to a sector average of just 6.5x. That leaves virtually no margin for error. Options markets are pricing in a 13% to 15% swing around the earnings release, consistent with the volatility seen in recent quarters.

Analysts Remain Bullish — With Caveats

Despite the risks, Wall Street isn't backing away. Morgan Stanley raised its price target to $58 after IonQ hit its AQ-64 benchmark ahead of schedule. Wedbush Securities maintains an "Outperform" rating with a $60 target. Northland Capital Markets initiated coverage at $55, calling IonQ the revenue leader in quantum computing — while explicitly flagging the persistent losses and stretched valuation.

The stock has traded largely sideways since the start of the year, even as the broader quantum sector gained 40%. That underperformance reflects the market's growing impatience with the gap between IonQ's growth story and its bottom-line reality.

If IonQ delivers within guidance and raises its full-year outlook tonight, the shares could finally trade on fundamentals rather than speculation. But if the outlook remains unchanged, the widening loss trajectory will once again take center stage — and at 59x sales, there's precious little room for disappointment.